Bavarian Nordic A/S (CPH:BAVA)
174.20
+0.45 (0.26%)
Feb 21, 2025, 4:59 PM CET
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.36B DKK in the quarter ending September 30, 2024, a decrease of -0.95%. This brings the company's revenue in the last twelve months to 6.07B, up 2.78% year-over-year. In the year 2023, Bavarian Nordic had annual revenue of 7.06B with 124.14% growth.
Revenue (ttm)
6.07B
Revenue Growth
+2.78%
P/S Ratio
2.25
Revenue / Employee
3.77M
Employees
1,379
Market Cap
13.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | 662.49M | 161.87M | 32.33% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 290.40B |
Coloplast | 27.45B |
Genmab | 21.53B |
Demant | 22.42B |
Zealand Pharma | 62.69M |
H. Lundbeck | 22.00B |
Ambu A/S | 5.65B |
ALK-Abelló | 5.54B |
Bavarian Nordic News
- 8 days ago - Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older - GlobeNewsWire
- 19 days ago - Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025 - GlobeNewsWire
- 22 days ago - Bavarian Nordic – Completion of Share Buy-Back Program - GlobeNewsWire
- 22 days ago - Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older - GlobeNewsWire
- 26 days ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - GlobeNewsWire
- 4 weeks ago - Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - GlobeNewsWire
- 6 weeks ago - Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million - GlobeNewsWire
- 2 months ago - Nigeria set to receive 11,200 doses of Mpox vaccine - Premium Times Nigeria